Array Array
you are here:

Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info

BSE Live

Jan 17, 16:00
486.25 10.10 (2.12%)
Volume
AVERAGE VOLUME
5-Day
98,023
10-Day
90,754
30-Day
95,930
90,692
  • Prev. Close

    476.15

  • Open Price

    476.30

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Jan 17, 15:59
485.95 10.10 (2.12%)
Volume
AVERAGE VOLUME
5-Day
2,728,268
10-Day
2,331,297
30-Day
2,519,707
2,644,076
  • Prev. Close

    475.85

  • Open Price

    477.40

  • Bid Price (Qty.)

    485.95 (53)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2019 2018 2017 2016 2015
Quarterly Results of Aurobindo Pharma (in Rs. Cr.) Sep '19 Jun '19 Mar '19 Dec '18 Sep '18  
Net Sales/Income from operations 3,145.12 2,997.03 3,196.20 3,160.50 3,090.38  
Other Operating Income 76.54 81.80 84.38 87.60 80.01  
Total Income From Operations 3,221.66 3,078.83 3,280.58 3,248.10 3,170.39  
EXPENDITURE  
Consumption of Raw Materials 1,586.16 1,615.40 1,708.20 1,704.14 1,608.99  
Purchase of Traded Goods 1.34 2.38 0.58 3.71 7.43  
Increase/Decrease in Stocks 38.01 -75.72 -136.90 -22.43 -11.34  
Power & Fuel -- -- -- -- --  
Employees Cost 374.06 377.56 361.82 349.86 331.80  
depreciat 117.93 115.15 109.33 109.10 100.94  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 590.88 608.80 612.54 614.50 626.54  
P/L Before Other Inc. , Int., Excpt. Items & Tax 513.28 435.26 625.01 489.22 506.03  
Other Income 33.64 30.14 28.31 136.87 4.18  
P/L Before Int., Excpt. Items & Tax 546.92 465.40 653.32 626.09 510.21  
Interest 24.86 31.95 34.84 41.41 30.80  
P/L Before Exceptional Items & Tax 522.06 433.45 618.48 584.68 479.41  
Exceptional Items -- -- -- -- --  
P/L Before Tax 522.06 433.45 618.48 584.68 479.41  
Tax 123.93 102.95 158.34 121.17 98.46  
P/L After Tax from Ordinary Activities 398.13 330.50 460.14 463.51 380.95  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 398.13 330.50 460.14 463.51 380.95  
Equity Share Capital 58.59 58.59 58.59 58.59 58.59  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 6.80 5.64 7.85 7.91 6.50  
Diluted EPS 6.80 5.64 7.85 7.91 6.50  
EPS After Extra Ordinary  
Basic EPS. 6.80 5.64 7.85 7.91 6.50  
Diluted EPS. 6.80 5.64 7.85 7.91 6.50  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited